PE Ratio: 22.79
Is the P/E ratio high or low?
The P/E ratio of 22.79 is 33% above its 5-year average of 17.12, near the high end of its 5-year range (7.75–24.59).
As of Friday, June 26, 2026. 4.87% above its 12-month average of 21.73.
PE Ratio (22.79) = Close Price ($206.24) / Diluted TTM EPS ($9.05)
DGX PE Ratio Chart
DGX Average PE Ratio Chart
DGX Current vs Average PE Ratio Chart
DGX PE Ratio Metrics
PE RATIO
22.79
PE RATIO AVG TTM
21.73
PE RATIO AVG 3Y
20.67
PE RATIO AVG 5Y
17.12
PE RATIO AVG 10Y
17.58
PE RATIO AVG 15Y
16.72
PE RATIO AVG 20Y
17.11
CURRENT VS TTM AVG
+4.87%
CURRENT VS 3Y AVG
+10.26%
CURRENT VS 5Y AVG
+33.09%
CURRENT VS 10Y AVG
+29.64%
CURRENT VS 15Y AVG
+36.29%
CURRENT VS 20Y AVG
+33.18%
DGX Competitors' PE Ratio
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quest Diagnostics Incorporated (DGX) | $22.83B | 22.79 | 21.73 | 20.67 | 17.12 |
| BioNTech SE (BNTX)vs › | $22.76B | N/A | 55.73 | 22.62 | 82.47 |
| United Therapeutics Corporation (UTHR)vs › | $23.07B | 20.09 | 17.34 | 14.99 | 16.04 |
| Moderna, Inc. (MRNA)vs › | $23.71B | N/A | 15.46 | 32.51 | 32.51 |
| Labcorp Holdings Inc. (LH)vs › | $21.83B | 23.58 | 26.97 | 32.22 | 23.50 |
| Incyte Corporation (INCY)vs › | $21.48B | 15.19 | 34.79 | 113.11 | 79.79 |
| Waters Corporation (WAT)vs › | $24.57B | 47.89 | 32.49 | 31.21 | 30.51 |
| Mettler-Toledo International Inc. (MTD)vs › | $25.13B | 29.11 | 31.91 | 32.72 | 36.25 |
| STERIS plc (STE)vs › | $20.52B | 26.56 | 34.67 | 61.15 | 67.61 |
| Veeva Systems Inc. (VEEV)vs › | $25.68B | 28.18 | 45.84 | 54.21 | 66.08 |
P/E vs. its own history
At 22.8, P/E is richer than usual, sitting higher than 94% of its 20-year history.
20-year low
7.8
median
17.8
20-year high
28.3
P/E Comparison
Trailing P/E
22.8
Forward P/E
17.7
Forward P/E Calculation
View All Analyst EstimatesForward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$206.24
Forward EPS (Est.)
$11.67
Forward P/E
17.67
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio Formula & Definition
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
PE Ratio FAQ
- What is the P/E ratio for Quest Diagnostics Incorporated (DGX)?
- The P/E ratio for DGX stock is 22.79.
- Is Quest Diagnostics Incorporated's P/E ratio high or low?
- The P/E ratio of 22.79 is 33% above its 5-year average of 17.12, near the high end of its 5-year range (7.75–24.59).
- What is the TTM average P/E ratio for Quest Diagnostics Incorporated (DGX)?
- The TTM average P/E ratio for DGX stock is 21.73.
- What is the 3Y average P/E ratio for Quest Diagnostics Incorporated (DGX)?
- The 3Y average P/E ratio for DGX stock is 20.67.
- What is the 5Y average P/E ratio for Quest Diagnostics Incorporated (DGX)?
- The 5Y average P/E ratio for DGX stock is 17.12.
- What is the 10Y average P/E ratio for Quest Diagnostics Incorporated (DGX)?
- The 10Y average P/E ratio for DGX stock is 17.58.
- What is the 15Y average P/E ratio for Quest Diagnostics Incorporated (DGX)?
- The 15Y average P/E ratio for DGX stock is 16.72.
- What is the 20Y average P/E ratio for Quest Diagnostics Incorporated (DGX)?
- The 20Y average P/E ratio for DGX stock is 17.11.
DGX PE Ratio History
| DATE | PE RATIO |
|---|---|
| 2026-06-25 | 22.79 |
| 2026-06-24 | 22.44 |
| 2026-06-23 | 21.79 |
| 2026-06-22 | 21.39 |
| 2026-06-18 | 21.55 |
| 2026-06-17 | 21.85 |
| 2026-06-16 | 22.21 |
| 2026-06-15 | 22.34 |
| 2026-06-12 | 22.44 |
| 2026-06-11 | 22.52 |
| 2026-06-10 | 22.52 |
| 2026-06-09 | 22.60 |
| 2026-06-08 | 21.79 |
| 2026-06-05 | 22.13 |
| 2026-06-04 | 21.67 |
| 2026-06-03 | 21.40 |
| 2026-06-02 | 21.34 |
| 2026-06-01 | 21.24 |
| 2026-05-29 | 21.54 |
| 2026-05-28 | 21.68 |
| 2026-05-27 | 21.44 |
| 2026-05-26 | 21.31 |
| 2026-05-22 | 21.57 |
| 2026-05-21 | 21.42 |
| 2026-05-20 | 21.41 |
| 2026-05-19 | 21.04 |
| 2026-05-18 | 20.98 |
| 2026-05-15 | 20.62 |
| 2026-05-14 | 20.77 |
| 2026-05-13 | 21.09 |
| 2026-05-12 | 21.01 |
| 2026-05-11 | 20.97 |
| 2026-05-08 | 20.71 |
| 2026-05-07 | 21.09 |
| 2026-05-06 | 20.90 |
| 2026-05-05 | 21.09 |
| 2026-05-04 | 21.16 |
| 2026-05-01 | 21.29 |
| 2026-04-30 | 21.46 |
| 2026-04-29 | 20.92 |
| 2026-04-28 | 21.55 |
| 2026-04-27 | 21.73 |
| 2026-04-24 | 21.69 |
| 2026-04-23 | 22.05 |
| 2026-04-22 | 22.54 |
| 2026-04-21 | 23.43 |
| 2026-04-20 | 22.44 |
| 2026-04-17 | 22.29 |
| 2026-04-16 | 21.88 |
| 2026-04-15 | 21.88 |
| 2026-04-14 | 22.19 |
| 2026-04-13 | 22.05 |
| 2026-04-10 | 21.89 |
| 2026-04-09 | 22.61 |
| 2026-04-08 | 22.72 |
| 2026-04-07 | 22.49 |
| 2026-04-06 | 22.74 |
| 2026-04-02 | 22.63 |
| 2026-04-01 | 22.59 |
| 2026-03-31 | 22.40 |
| 2026-03-30 | 22.53 |
| 2026-03-27 | 22.34 |
| 2026-03-26 | 22.65 |
| 2026-03-25 | 22.45 |
| 2026-03-24 | 22.41 |
| 2026-03-23 | 22.35 |
| 2026-03-20 | 22.32 |
| 2026-03-19 | 22.19 |
| 2026-03-18 | 22.31 |
| 2026-03-17 | 22.70 |
| 2026-03-16 | 22.74 |
| 2026-03-13 | 22.82 |
| 2026-03-12 | 22.96 |
| 2026-03-11 | 22.92 |
| 2026-03-10 | 22.96 |
| 2026-03-09 | 23.04 |
| 2026-03-06 | 22.77 |
| 2026-03-05 | 23.31 |
| 2026-03-04 | 23.82 |
| 2026-03-03 | 23.81 |
| 2026-03-02 | 24.03 |
| 2026-02-27 | 24.22 |
| 2026-02-26 | 24.13 |
| 2026-02-25 | 24.39 |
| 2026-02-24 | 24.59 |
| 2026-02-23 | 24.35 |
| 2026-02-20 | 23.76 |
| 2026-02-19 | 23.76 |
| 2026-02-18 | 23.99 |
| 2026-02-17 | 24.12 |
| 2026-02-13 | 24.28 |
| 2026-02-12 | 24.28 |
| 2026-02-11 | 24.57 |
| 2026-02-10 | 24.10 |
| 2026-02-09 | 22.45 |
| 2026-02-06 | 22.38 |
| 2026-02-05 | 22.57 |
| 2026-02-04 | 22.21 |
| 2026-02-03 | 21.73 |
| 2026-02-02 | 21.71 |
| 2026-01-30 | 21.95 |
| 2026-01-29 | 21.40 |
| 2026-01-28 | 21.45 |
| 2026-01-27 | 21.62 |
| 2026-01-26 | 21.42 |
| 2026-01-23 | 21.25 |
| 2026-01-22 | 21.38 |
| 2026-01-21 | 21.67 |
| 2026-01-20 | 22.18 |
| 2026-01-16 | 22.24 |
| 2026-01-15 | 22.33 |
| 2026-01-14 | 21.92 |
| 2026-01-13 | 21.12 |
| 2026-01-12 | 20.65 |
| 2026-01-09 | 20.47 |
| 2026-01-08 | 20.86 |
| 2026-01-07 | 20.91 |
| 2026-01-06 | 21.18 |
| 2026-01-05 | 20.36 |
| 2026-01-02 | 20.40 |
| 2025-12-31 | 20.37 |
| 2025-12-30 | 20.60 |
| 2025-12-29 | 20.60 |
| 2025-12-26 | 20.65 |
| 2025-12-24 | 20.65 |
| 2025-12-23 | 20.55 |
| 2025-12-22 | 20.70 |
| 2025-12-19 | 20.66 |
| 2025-12-18 | 20.67 |
| 2025-12-17 | 21.02 |
| 2025-12-16 | 20.97 |
| 2025-12-15 | 21.61 |
| 2025-12-12 | 21.43 |
| 2025-12-11 | 21.31 |
| 2025-12-10 | 21.07 |
| 2025-12-09 | 21.08 |
| 2025-12-08 | 21.34 |
| 2025-12-05 | 21.42 |
| 2025-12-04 | 21.62 |
| 2025-12-03 | 21.43 |
| 2025-12-02 | 21.43 |
| 2025-12-01 | 21.57 |
| 2025-11-28 | 22.20 |
| 2025-11-26 | 22.26 |
| 2025-11-25 | 22.58 |
| 2025-11-24 | 22.37 |
| 2025-11-21 | 22.45 |
| 2025-11-20 | 22.02 |
| 2025-11-19 | 21.83 |
| 2025-11-18 | 21.75 |
| 2025-11-17 | 21.85 |
| 2025-11-14 | 21.94 |
| 2025-11-13 | 22.02 |
| 2025-11-12 | 21.93 |
| 2025-11-11 | 22.17 |
| 2025-11-10 | 21.63 |
| 2025-11-07 | 21.07 |
| 2025-11-06 | 20.72 |
| 2025-11-05 | 20.92 |
| 2025-11-04 | 20.90 |
| 2025-11-03 | 20.99 |
| 2025-10-31 | 20.65 |
| 2025-10-30 | 20.63 |
| 2025-10-29 | 20.51 |
| 2025-10-28 | 20.92 |
| 2025-10-27 | 21.16 |
| 2025-10-24 | 21.38 |
| 2025-10-23 | 21.51 |
| 2025-10-22 | 21.26 |
| 2025-10-21 | 21.67 |
| 2025-10-20 | 22.80 |
| 2025-10-17 | 22.70 |
| 2025-10-16 | 22.37 |
| 2025-10-15 | 22.44 |
| 2025-10-14 | 22.20 |
| 2025-10-13 | 21.89 |
| 2025-10-10 | 22.04 |
| 2025-10-09 | 21.73 |
| 2025-10-08 | 21.66 |
| 2025-10-07 | 21.78 |
| 2025-10-06 | 21.37 |
| 2025-10-03 | 21.48 |
| 2025-10-02 | 21.67 |
| 2025-10-01 | 21.80 |
| 2025-09-30 | 22.82 |
| 2025-09-29 | 22.62 |
| 2025-09-26 | 22.63 |
| 2025-09-25 | 22.20 |
| 2025-09-24 | 22.37 |
| 2025-09-23 | 22.39 |
| 2025-09-22 | 22.12 |
| 2025-09-19 | 21.99 |
| 2025-09-18 | 21.96 |
| 2025-09-17 | 21.83 |
| 2025-09-16 | 21.58 |
| 2025-09-15 | 21.63 |
| 2025-09-12 | 21.91 |
| 2025-09-11 | 21.97 |
| 2025-09-10 | 21.57 |
| 2025-09-09 | 21.88 |
| 2025-09-08 | 21.86 |
| 2025-09-05 | 21.97 |
| 2025-09-04 | 21.57 |
| 2025-09-03 | 21.50 |
| 2025-09-02 | 21.40 |
| 2025-08-29 | 21.75 |
| 2025-08-28 | 21.46 |
| 2025-08-27 | 21.53 |
| 2025-08-26 | 21.60 |
| 2025-08-25 | 21.40 |
| 2025-08-22 | 21.58 |
| 2025-08-21 | 22.00 |
| 2025-08-20 | 22.08 |
| 2025-08-19 | 21.90 |
| 2025-08-18 | 21.43 |
| 2025-08-15 | 21.53 |
| 2025-08-14 | 21.37 |
| 2025-08-13 | 21.44 |
| 2025-08-12 | 21.40 |
| 2025-08-11 | 21.36 |
| 2025-08-08 | 21.19 |
| 2025-08-07 | 20.87 |
| 2025-08-06 | 20.72 |
| 2025-08-05 | 20.75 |
| 2025-08-04 | 20.65 |
| 2025-08-01 | 20.46 |
| 2025-07-31 | 20.05 |
| 2025-07-30 | 20.21 |
| 2025-07-29 | 20.11 |
| 2025-07-28 | 20.10 |
| 2025-07-25 | 20.19 |
| 2025-07-24 | 20.59 |
| 2025-07-23 | 20.42 |
| 2025-07-22 | 22.51 |
| 2025-07-21 | 21.02 |
| 2025-07-18 | 21.07 |
| 2025-07-17 | 21.23 |
| 2025-07-16 | 21.09 |
| 2025-07-15 | 21.01 |
| 2025-07-14 | 21.26 |
| 2025-07-11 | 21.22 |
| 2025-07-10 | 21.65 |
| 2025-07-09 | 21.92 |
| 2025-07-08 | 21.78 |
| 2025-07-07 | 21.97 |
| 2025-07-03 | 22.34 |
| 2025-07-02 | 22.30 |
| 2025-07-01 | 22.64 |
| 2025-06-30 | 22.68 |
| 2025-06-27 | 22.45 |
| 2025-06-26 | 22.36 |
| 2025-06-25 | 22.56 |
| 2025-06-24 | 22.71 |
| 2025-06-23 | 22.69 |
| 2025-06-20 | 22.66 |
| 2025-06-18 | 22.70 |
| 2025-06-17 | 22.59 |
| 2025-06-16 | 22.99 |
| 2025-06-13 | 22.75 |
| 2025-06-12 | 22.61 |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
About Quest Diagnostics Incorporated
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- James E. Davis